Page last updated: 2024-09-05

alagebrium and ramipril

alagebrium has been researched along with ramipril in 2 studies

Compound Research Comparison

Studies (alagebrium)	Trials (alagebrium)	Recent Studies (post-2010) (alagebrium)	Studies (ramipril)	Trials (ramipril)	Recent Studies (post-2010) (ramipril)
83	10	31	2,151	606	509

Protein Interaction Comparison

Protein	Taxonomy	alagebrium (IC50)	ramipril (IC50)
Angiotensin-converting enzyme	Homo sapiens (human)		0.004
Angiotensin-converting enzyme	Oryctolagus cuniculus (rabbit)		0.253

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cooper, M; Forbes, J; Jerums, G; Osicka, T; Panagiotopoulos, S	1
Arnstein, M; Cooper, ME; Coughlan, MT; Forbes, JM; Gasser, A; Long, DM; Pete, J; Thallas-Bonke, V; Thorpe, SR; Tong, DC	1

Reviews

1 review(s) available for alagebrium and ramipril

Article	Year
Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Archives of biochemistry and biophysics, 2003, Nov-01, Volume: 419, Issue:1 Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Inhibitors; Forecasting; Glycation End Products, Advanced; Guanidines; Humans; Protein Kinase C; Ramipril; Renin-Angiotensin System; Thiazoles	2003

Article

Year

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.

Archives of biochemistry and biophysics, 2003, Nov-01, Volume: 419, Issue:1

Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Inhibitors; Forecasting; Glycation End Products, Advanced; Guanidines; Humans; Protein Kinase C; Ramipril; Renin-Angiotensin System; Thiazoles

2003

Other Studies

1 other study(ies) available for alagebrium and ramipril

Article	Year
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology, 2007, Volume: 148, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cytosol; Diabetes Mellitus, Experimental; Drug Synergism; Drug Therapy, Combination; Enzyme Activation; Glycation End Products, Advanced; Kidney; Lysine; Male; Mitochondria; NF-kappa B; Oxidative Stress; Protein Kinase C; Ramipril; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin-Angiotensin System; Superoxide Dismutase; Thiazoles; Vascular Endothelial Growth Factor A	2007

Article

Year

Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?

Endocrinology, 2007, Volume: 148, Issue:2

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cytosol; Diabetes Mellitus, Experimental; Drug Synergism; Drug Therapy, Combination; Enzyme Activation; Glycation End Products, Advanced; Kidney; Lysine; Male; Mitochondria; NF-kappa B; Oxidative Stress; Protein Kinase C; Ramipril; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin-Angiotensin System; Superoxide Dismutase; Thiazoles; Vascular Endothelial Growth Factor A

2007